TOMM40 Knockdown in Macrophages Inhibits Oxidized LDL-induced NLRP3 Activation and Promotes LXR-β Mediated Cholesterol Transporter Gene Expression
Chelluri, S. S.; Yang, N. V.; Theusch, E.; Krauss, R. M.
Show abstract
Atherogenesis has been shown in mice to be dependent on activation of the NLRP3 inflammasome, a cytosolic innate immune sensor activated by a broad range of pathogen and damage associated molecular patterns, including oxidized LDL (oxLDL) in atherosclerosis. Previous work from our group has shown that knockdown of Translocase of Outer Mitochondrial Membrane 40 (TOMM40), which encodes a component of the mitochondrial importer TOM complex, increases expression and activity of the nuclear receptor-family transcription factor, liver X receptor (LXR) in hepatocytes. As LXR agonists have been shown to inhibit NLRP3 activation, we confirmed the prediction that TOMM40 knockdown has this effect in THP-1 monocyte-derived macrophages. Further, we demonstrated that TOMM40 KD upregulates LXR-mediated macrophage expression of the ABCA1 and ABCG1 genes which encode transporters that promote cellular cholesterol efflux, the first step in reverse cholesterol transport to the liver. Taken together, these findings identify a novel mechanism whereby increased LXR activity induced by suppression of TOMM40 expression in macrophages may retard atherogenesis both by inhibiting inflammation and promoting reverse cholesterol transport.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver 95%
- Statin-mediated reduction in mitochondrial cholesterol primes an anti-inflammatory response in macrophages by upregulating JMJD3 94%
- p38γ and p38δ modulate innate immune response by regulating MEF2D activation 94%
Similar papers in this journal
Similar papers in this journal
- Liver-specific LXR inhibition represses reverse cholesterol transport in cholesterol-fed mice 93%
- Enhancement of High-Density Lipoprotein-Associated Protease Inhibitor Activity Prevents Atherosclerosis Progression 92%
- Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formation 92%
Similar papers in this journal
- Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol 95%
- 4 β-hydroxycholesterol is a pro-lipogenic factor that promotes SREBP1c expression and activity through Liver X-receptor. 94%
- Aggressive Cholesterol Lowering Normalizes Atherosclerosis Regression in Jak2V617F Mice 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.